Bacterial vaginosis screening

Sexually transmitted diseases Main Page
Vaginitis Main Page
Bacterial vaginosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Bacterial vaginosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Amsel Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bacterial vaginosis screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bacterial vaginosis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bacterial vaginosis screening
CDC on Bacterial vaginosis screening
Bacterial vaginosis screening in the news
Blogs on Bacterial vaginosis screening
Directions to Hospitals Treating Bacterial vaginosis
Risk calculators and risk factors for Bacterial vaginosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

General screening for bacterial vaginosis is not recommended. According to the United States Preventive Services Task Force, evidence is insufficient to recommend routine screening for bacterial vaginosis (BV) in asymptomatic pregnant women at high or low risk for preterm delivery for the prevention of preterm birth.

Screening

According to the United States Preventive Services task force:

Population	Screening Recommendations
Asymptomatic Pregnant Women, Low Risk	The USPSTF recommends against screening for bacterial vaginosis in asymptomatic pregnant women at low risk for preterm delivery
Asymptomatic Pregnant Women, High Risk	The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bacterial vaginosis in asymptomatic pregnant women at high risk for preterm delive